Cargando…

Resistance to lethal ectromelia virus infection requires Type I interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cells

Type I interferons (IFN-I) are antiviral cytokines that signal through the ubiquitous IFN-I receptor (IFNAR). Following footpad infection with ectromelia virus (ECTV), a mouse-specific pathogen, C57BL/6 (B6) mice survive without disease, while B6 mice broadly deficient in IFNAR succumb rapidly. We n...

Descripción completa

Detalles Bibliográficos
Autores principales: Melo-Silva, Carolina R., Alves-Peixoto, Pedro, Heath, Natasha, Tang, Lingjuan, Montoya, Brian, Knudson, Cory J., Stotesbury, Colby, Ferez, Maria, Wong, Eric, Sigal, Luis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172060/
https://www.ncbi.nlm.nih.gov/pubmed/34015056
http://dx.doi.org/10.1371/journal.ppat.1009593
_version_ 1783702470114934784
author Melo-Silva, Carolina R.
Alves-Peixoto, Pedro
Heath, Natasha
Tang, Lingjuan
Montoya, Brian
Knudson, Cory J.
Stotesbury, Colby
Ferez, Maria
Wong, Eric
Sigal, Luis J.
author_facet Melo-Silva, Carolina R.
Alves-Peixoto, Pedro
Heath, Natasha
Tang, Lingjuan
Montoya, Brian
Knudson, Cory J.
Stotesbury, Colby
Ferez, Maria
Wong, Eric
Sigal, Luis J.
author_sort Melo-Silva, Carolina R.
collection PubMed
description Type I interferons (IFN-I) are antiviral cytokines that signal through the ubiquitous IFN-I receptor (IFNAR). Following footpad infection with ectromelia virus (ECTV), a mouse-specific pathogen, C57BL/6 (B6) mice survive without disease, while B6 mice broadly deficient in IFNAR succumb rapidly. We now show that for survival to ECTV, only hematopoietic cells require IFNAR expression. Survival to ECTV specifically requires IFNAR in both natural killer (NK) cells and monocytes. However, intrinsic IFNAR signaling is not essential for adaptive immune cell responses or to directly protect non-hematopoietic cells such as hepatocytes, which are principal ECTV targets. Mechanistically, IFNAR-deficient NK cells have reduced cytolytic function, while lack of IFNAR in monocytes dampens IFN-I production and hastens virus dissemination. Thus, during a pathogenic viral infection, IFN-I coordinates innate immunity by stimulating monocytes in a positive feedback loop and by inducing NK cell cytolytic function.
format Online
Article
Text
id pubmed-8172060
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-81720602021-06-14 Resistance to lethal ectromelia virus infection requires Type I interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cells Melo-Silva, Carolina R. Alves-Peixoto, Pedro Heath, Natasha Tang, Lingjuan Montoya, Brian Knudson, Cory J. Stotesbury, Colby Ferez, Maria Wong, Eric Sigal, Luis J. PLoS Pathog Research Article Type I interferons (IFN-I) are antiviral cytokines that signal through the ubiquitous IFN-I receptor (IFNAR). Following footpad infection with ectromelia virus (ECTV), a mouse-specific pathogen, C57BL/6 (B6) mice survive without disease, while B6 mice broadly deficient in IFNAR succumb rapidly. We now show that for survival to ECTV, only hematopoietic cells require IFNAR expression. Survival to ECTV specifically requires IFNAR in both natural killer (NK) cells and monocytes. However, intrinsic IFNAR signaling is not essential for adaptive immune cell responses or to directly protect non-hematopoietic cells such as hepatocytes, which are principal ECTV targets. Mechanistically, IFNAR-deficient NK cells have reduced cytolytic function, while lack of IFNAR in monocytes dampens IFN-I production and hastens virus dissemination. Thus, during a pathogenic viral infection, IFN-I coordinates innate immunity by stimulating monocytes in a positive feedback loop and by inducing NK cell cytolytic function. Public Library of Science 2021-05-20 /pmc/articles/PMC8172060/ /pubmed/34015056 http://dx.doi.org/10.1371/journal.ppat.1009593 Text en © 2021 Melo-Silva et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Melo-Silva, Carolina R.
Alves-Peixoto, Pedro
Heath, Natasha
Tang, Lingjuan
Montoya, Brian
Knudson, Cory J.
Stotesbury, Colby
Ferez, Maria
Wong, Eric
Sigal, Luis J.
Resistance to lethal ectromelia virus infection requires Type I interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cells
title Resistance to lethal ectromelia virus infection requires Type I interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cells
title_full Resistance to lethal ectromelia virus infection requires Type I interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cells
title_fullStr Resistance to lethal ectromelia virus infection requires Type I interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cells
title_full_unstemmed Resistance to lethal ectromelia virus infection requires Type I interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cells
title_short Resistance to lethal ectromelia virus infection requires Type I interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cells
title_sort resistance to lethal ectromelia virus infection requires type i interferon receptor in natural killer cells and monocytes but not in adaptive immune or parenchymal cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172060/
https://www.ncbi.nlm.nih.gov/pubmed/34015056
http://dx.doi.org/10.1371/journal.ppat.1009593
work_keys_str_mv AT melosilvacarolinar resistancetolethalectromeliavirusinfectionrequirestypeiinterferonreceptorinnaturalkillercellsandmonocytesbutnotinadaptiveimmuneorparenchymalcells
AT alvespeixotopedro resistancetolethalectromeliavirusinfectionrequirestypeiinterferonreceptorinnaturalkillercellsandmonocytesbutnotinadaptiveimmuneorparenchymalcells
AT heathnatasha resistancetolethalectromeliavirusinfectionrequirestypeiinterferonreceptorinnaturalkillercellsandmonocytesbutnotinadaptiveimmuneorparenchymalcells
AT tanglingjuan resistancetolethalectromeliavirusinfectionrequirestypeiinterferonreceptorinnaturalkillercellsandmonocytesbutnotinadaptiveimmuneorparenchymalcells
AT montoyabrian resistancetolethalectromeliavirusinfectionrequirestypeiinterferonreceptorinnaturalkillercellsandmonocytesbutnotinadaptiveimmuneorparenchymalcells
AT knudsoncoryj resistancetolethalectromeliavirusinfectionrequirestypeiinterferonreceptorinnaturalkillercellsandmonocytesbutnotinadaptiveimmuneorparenchymalcells
AT stotesburycolby resistancetolethalectromeliavirusinfectionrequirestypeiinterferonreceptorinnaturalkillercellsandmonocytesbutnotinadaptiveimmuneorparenchymalcells
AT ferezmaria resistancetolethalectromeliavirusinfectionrequirestypeiinterferonreceptorinnaturalkillercellsandmonocytesbutnotinadaptiveimmuneorparenchymalcells
AT wongeric resistancetolethalectromeliavirusinfectionrequirestypeiinterferonreceptorinnaturalkillercellsandmonocytesbutnotinadaptiveimmuneorparenchymalcells
AT sigalluisj resistancetolethalectromeliavirusinfectionrequirestypeiinterferonreceptorinnaturalkillercellsandmonocytesbutnotinadaptiveimmuneorparenchymalcells